- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.07. | Sunshine Biopharma, Inc - 8-K, Current Report | 4 | SEC Filings | ||
| 07.06. | Sunshine Biopharma, Inc - 8-K, Current Report | 10 | SEC Filings | ||
| 22.05. | Sunshine Biopharma, Inc - 8-K, Current Report | 2 | SEC Filings | ||
| 21.05. | Sunshine Biopharma reports Q1 results | 5 | Seeking Alpha | ||
| 21.05. | Sunshine Biopharma, Inc.: Sunshine Biopharma Reports 2024 First Quarter Results: Revenues Up 54% | 433 | ACCESSWIRE | NEW YORK, NY / ACCESSWIRE / May 21, 2024 / Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic... ► Artikel lesen | |
| 20.05. | Sunshine Biopharma Inc reports results for the quarter ended in March - Earnings Summary | 2 | Reuters | ||
| 20.05. | Sunshine Biopharma, Inc - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 15.05. | Sunshine Biopharma, Inc - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | 3 | SEC Filings | ||
| 07.05. | Sunshine Biopharma Inc expected to post a loss of $8.00 a share - Earnings Preview | 10 | Reuters | ||
| 06.05. | Sunshine Biopharma, Inc - 8-K, Current Report | 3 | SEC Filings | ||
| 23.04. | Sunshine Biopharma, Inc - 8-K, Current Report | 6 | SEC Filings | ||
| 23.04. | Bio-Path Holdings, Sunshine Biopharma, INVO Bioscience among healthcare movers | 4 | Seeking Alpha | ||
| 22.04. | SBFM, BPTH and INDO among pre-market losers | 5 | Seeking Alpha | ||
| 19.04. | Pre-market Movers: Zhongchao, Redwoods Acquisition Corp., Tritium DCFC, Nexalin Technology, Sunshine Biopharma | 1.208 | AFX News | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 08.05 A.M. ET).In the Green Zhongchao Inc. (ZCMD) is up over 96% at $2.83.
Redwoods... ► Artikel lesen | |
| 19.04. | Sunshine biopharma's Nora Pharma receives Health Canada approval for Niopeg | 4 | Seeking Alpha | ||
| 19.04. | Sunshine Biopharma, Inc.: Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg, a Biosimilar of Neulasta | 725 | ACCESSWIRE | NEW YORK, NY / ACCESSWIRE / April 19, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including... ► Artikel lesen | |
| 15.04. | How Is The Market Feeling About Sunshine Biopharma? | 2 | Benzinga.com | ||
| 12.04. | Sunshine Biopharma, Inc.: Sunshine Biopharma Announces Reverse Stock Split | 501 | ACCESSWIRE | NEW YORK, NY / ACCESSWIRE / April 12, 2024 / Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the "Company" or "Sunshine Biopharma"), a pharmaceutical company offering and researching life-saving medicines in... ► Artikel lesen | |
| 01.04. | Sunshine Biopharma, Inc - 8-K, Current Report | 3 | SEC Filings | ||
| 01.04. | Sunshine Biopharma reports FY results | 2 | Seeking Alpha |
Seite:
1 2 Weiter >>
36 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ASTRIA THERAPEUTICS | 11,300 | +2,73 % | Astria Therapeutics, Inc.: Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress | Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced that it will present two... ► Artikel lesen | |
| ORAMED PHARMACEUTICALS | 2,326 | -0,13 % | Oramed Pharmaceuticals Inc.: Oramed Letter to Shareholders | Stock Repurchase Program
Scilex Senior Secured Note
Phase 3 Oral Insulin Trial in US
JV with Chinese Partner, HTIT
NEW YORK, June 26, 2024 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq:... ► Artikel lesen | |
| CASSAVA SCIENCES | 13,760 | +0,15 % | Buy Aehr Test Systems, Sell Cassava Sciences | ||
| ROCKET LAB USA | 5,040 | +1,41 % | Mynaric AG: Mynaric Selected by Rocket Lab for Space Development Agency's Tranche 2 Transport Layer - Beta Program | Laser Communications Manufacturer Expands Customer RosterLOS ANGELES, CA / ACCESSWIRE / May 7, 2024 / Mynaric (NASDAQ:MYNA)(FRA:M0YN), a leading provider of industrialized, cost-effective and scalable... ► Artikel lesen | |
| BOIRON | 31,800 | 0,00 % | BOIRON: EVOLUTION OF GOVERNANCE | July 3rd, 2024
The Board of Directors of Laboratoires BOIRON, meeting today under the chairmanship of Thierry BOIRON, has enacted an evolution of the Group's governance.
In this context, Thierry... ► Artikel lesen | |
| LIPOCINE | 5,570 | -4,30 % | Lipocine Inc.: Lipocine Presents 52 Week Results from LPCN 1148 Phase 2 Study in Late Breaking Session at EASL Congress 2024 | SALT LAKE CITY, June 10, 2024 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company, today announced that Phase 2 results on LPCN 1148 in cirrhosis were featured in a late breaking... ► Artikel lesen | |
| HARROW | 24,440 | +0,87 % | Harrow, Inc.: Harrow to Attend 2024 ASRS Annual Meeting | Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that its management team would attend the 2024 American Society of Retina Specialists (ASRS) Annual... ► Artikel lesen | |
| ALLERGY THERAPEUTICS | 0,053 | -4,50 % | Allergy Therapeutics Projects FY Revenue Down 7%; Sees Revenue Growth In H2 | ||
| MEDICINOVA | 1,200 | -1,64 % | MediciNova, Inc.: MediciNova Announces Data from Phase 1b/2a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Patients at the American Society of Clinical Oncology (ASCO) Annual Meeting 2024 | LA JOLLA, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange... ► Artikel lesen | |
| ESSA PHARMA | 5,300 | -2,21 % | ESSA Pharma Inc: ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024 | Combination of masofaniten plus enzalutamide continues to be well tolerated with deep and durable reductions in PSA in Phase 1 dose escalation in patients with mCRPC naïve to second generation antiandrogens... ► Artikel lesen | |
| AQUESTIVE THERAPEUTICS | 3,825 | +10,87 % | Aquestive Therapeutics, Inc.: Aquestive Therapeutics Reports Positive Topline Data for Anaphylm (epinephrine) Sublingual Film from Self-Administration Study | Meets primary study endpoints with pharmacokinetics (PK) comparable whether Anaphylm is administered by subjects or by healthcare providers (HCPs)Final supportive study, the Oral Allergy Syndrome... ► Artikel lesen | |
| REVIVA PHARMACEUTICALS | 1,240 | -1,59 % | Reviva Pharmaceuticals: Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Hypertension | - Patent covers brilaroxazine use for treating pulmonary hypertension (PH), pulmonary arterial hypertension (PAH) in any patients including treating PH in patients with chronic obstructive pulmonary... ► Artikel lesen | |
| CYANOTECH | 0,260 | 0,00 % | Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2024 | KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Corporation (OTCQB Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial... ► Artikel lesen | |
| CUMBERLAND PHARMACEUTICALS | 1,460 | 0,00 % | Cumberland Pharmaceuticals Inc.: Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company Update | NASHVILLE, TENN., May 7, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, today announced that its product portfolio of FDA-approved brands... ► Artikel lesen | |
| SHINECO | 0,680 | 0,00 % | Shineco, Inc.: Shineco Regains Compliance with Nasdaq Minimum Bid Price Requirement | BEIJING, June 27, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a producer of innovative diagnostic medical products and related medical devices, announced today... ► Artikel lesen |
Das Unternehmen SUNSHINE BIOPHARMA INC kann der Branche Pharma zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,003 (-0,92 %) liegt der Kurs bei 0,300 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SUNSHINE BIOPHARMA INC finden Sie auf Wallstreet Online.
